Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.63M Buy
7,571
+7,205
+1,969% +$3.69M 0.01% 1191
2025
Q4
$205K Sell
366
-245
-40% -$139K ﹤0.01% 2623
2025
Q3
$314K Sell
611
-17,722
-97% -$7.74M ﹤0.01% 2141
2025
Q2
$5.75M Buy
+18,333
New +$5.5M 0.03% 473
2025
Q1
Sell
-4,345
Closed -$1.44M 3037
2024
Q4
$1.44M Buy
4,345
+70
+2% +$23.7K 0.01% 886
2024
Q3
$1.43M Buy
+4,275
New +$1.62M 0.01% 1039
2024
Q2
Sell
-5,039
Closed -$2.04M 2736
2024
Q1
$2.04M Buy
+5,039
New +$1.77M 0.01% 562
2023
Q4
Sell
-13,083
Closed -$3.17M 2774
2023
Q3
$3.17M Sell
13,083
-79,554
-86% -$20.3M 0.03% 443
2023
Q2
$22.2M Buy
92,637
+78,269
+545% +$16.3M 0.21% 61
2023
Q1
$2.7M Buy
+14,368
New +$2.97M 0.03% 465
2022
Q4
Sell
-44,431
Closed -$6.98M 2867
2022
Q3
$6.98M Buy
44,431
+13,302
+43% +$2.12M 0.08% 210
2022
Q2
$4.66M Buy
31,129
+24,214
+350% +$3.51M 0.05% 270
2022
Q1
$1.13M Buy
6,915
+1,858
+37% +$306K 0.01% 941
2021
Q4
$1.1M Buy
5,057
+2,747
+119% +$575K 0.01% 1029
2021
Q3
$437K Sell
2,310
-6,759
-75% -$1.23M ﹤0.01% 2130
2021
Q2
$1.6M Buy
+9,069
New +$1.57M 0.01% 737
2020
Q3
Sell
-14,009
Closed -$1.3M 2182
2020
Q2
$1.3M Buy
+14,009
New +$1.19M 0.04% 461
2020
Q1
Sell
-6,053
Closed -$508K 1122
2019
Q4
$508K Buy
+6,053
New +$468K 0.02% 528

Other funds holding MEDP

HRT Financial's MEDP Position: Q1 2026 in Review

HRT Financial increased its Medpace (MEDP) stake by 1,969% in Q1 2026, buying an estimated $3.69M and bringing the position to 7,571 shares worth $3.63M. The position accounts for 0.01% of the portfolio, ranked #1191.

HRT Financial first reported a position in MEDP in Q4 2019 and has held it in 18 quarters since. The position peaked at $22.2M in Q2 2023. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • HRT Financial held 7,571 shares of Medpace worth $3.63M as of Q1 2026.
  • HRT Financial bought 7,205 Medpace shares in Q1 2026, an estimated $3.69M.
  • Medpace made up 0.01% of HRT Financial's portfolio in Q1 2026, its #1191 holding.
  • HRT Financial first reported a position in Medpace in Q4 2019 and has held it in 18 quarters since.
  • HRT Financial's Medpace position peaked at $22.2M in Q2 2023.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.